Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2018
has subject area
- Heparin, Low-Molecular-Weight (MeSH)
- Humans (MeSH)
- Pyridines (MeSH)
- Thiazoles (MeSH)
- Venous Thromboembolism (MeSH)
published in
- BMJ Evidence-Based Medicine Journal